{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:04:24Z","timestamp":1781625864760,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T00:00:00Z","timestamp":1765152000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":35,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rare coagulation factor deficiency (RFD) is characterized by a deficiency of factor (F) I, FII, FV, FVII, FX, FXI, FXII, FXIII, or a combined deficiency of FV\u2009+\u2009FVIII or vitamin K-dependent factors and accounts for approximately 5% of all bleeding disorders. The prevalence of RFD in the general population can range from 1 in 1,000,000 for FX to 1 in 2\u20133\u00a0million for FXIII. Combined deficiencies of vitamin K-related factors have been reported in 30 families worldwide. These patients can present with a wide range of clinical symptoms, from mucocutaneous bleeding to life-threatening symptoms such as central nervous system and gastrointestinal bleeding. Treatment of these disorders is primarily based on the replacement of the deficient factor.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this retrospective study, data from 92 children with RFDs were analyzed to describe the distribution, clinical features, treatment patterns, and outcomes of RFDs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The most common factor deficiencies were F VII and F XII deficiency and while combined vitamin-K dependent coagulation factor was found in 3 patients. Of the 92 patients included in the study, 72 exhibited bruising and\/or bleeding. The most common type of bleeding was oral and nasal mucosal bleeding. Factor activity was \u2264\u20095% in 22 patients, 6\u201320% in 12 patients, and 20\u201350% in the remaining 60 patients. Among patients with factor levels\u2009&lt;\u20095%, there were both patients without bleeding and patients with recurrent cerebral hemorrhage. Similarly, when factor levels reached 50%, some patients experienced bleeding while others remained asymptomatic. Acute and severe bleeding was controlled with treatment in nine patients. Twenty-seven patients with recurrent bleeding symptoms received prophylaxis. RFDs are more common in regions with high rates of consanguineous marriage, which was 29% in our study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>No significant results were obtained regarding an increased risk of bleeding as factor plasmatic levels decreased in patients with RFD. Because of its autosomal recessive inheritance, improving access to genetic counseling and testing is important. Delays in diagnosis and treatment and lack of appropriate prevention are important risk factors that increase life-threatening bleeding.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-02169-3","type":"journal-article","created":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T16:06:31Z","timestamp":1765209991000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vitamin K-dependent and other rare coagulation factor deficiencies: a single-center experience"],"prefix":"10.1186","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8449-4778","authenticated-orcid":false,"given":"\u00d6zlem","family":"Terzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sad\u0131k Sami","family":"Hatipo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"2169_CR1","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/hae.12402","volume":"4","author":"P James","year":"2014","unstructured":"James P, Salomon O, Mikovic D, Peyvandi F. Rare bleeding disorders - bleeding assessment tools, laboratory aspects and phenotype and therapy of FXI deficiency. Haemophilia. 2014;4:71\u20135.","journal-title":"Haemophilia"},{"key":"2169_CR2","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.transci.2018.10.009","volume":"57","author":"S Jain","year":"2018","unstructured":"Jain S, Acharya SS. Management of rare coagulation disorders in 2018. Transfus Apher Sci. 2018;57:705\u201312.","journal-title":"Transfus Apher Sci"},{"key":"2169_CR3","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1055\/s-0033-1349221","volume":"39","author":"F Peyvandi","year":"2013","unstructured":"Peyvandi F, Menegatti M, Palla R. Rare bleeding disorders: worldwide efforts for classification, diagnosis, and management. Semin Thromb Hemost. 2013;39:579\u201384.","journal-title":"Semin Thromb Hemost"},{"key":"2169_CR4","doi-asserted-by":"publisher","first-page":"2052","DOI":"10.1182\/blood-2014-08-532820","volume":"125","author":"R Palla","year":"2015","unstructured":"Palla R, Peyvandi F, Shapiro AD. Rare bleeding disorders: diagnosis and treatment. Blood. 2015;125:2052\u201361.","journal-title":"Blood"},{"key":"2169_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1365-2516.2006.01263.x","volume":"12","author":"F Peyvandi","year":"2006","unstructured":"Peyvandi F, Jayandharan G, Chandy M, Srivastava A, Nakaya SM, Johnson MJ, et al. Genetic diagnosis of haemophilia and other inherited bleeding disorders. Haemophilia. 2006;12:82\u20139.","journal-title":"Haemophilia"},{"key":"2169_CR6","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/bjh.13058","volume":"167","author":"AD Mumford","year":"2014","unstructured":"Mumford AD, Ackroyd S, Alikhan R, Bowles L, Chowdary P, Grainger J, et al. Guideline for the diagnosis and management of the rare coagulation disorders: a united Kingdom haemophilia centre doctors\u2019 organization guideline on behalf of the British committee for standards in haematology. Br J Haematol. 2014;167:304\u201326.","journal-title":"Br J Haematol"},{"key":"2169_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.hoc.2021.07.009","volume":"35","author":"A Pelcovits","year":"2021","unstructured":"Pelcovits A, Schiffman F, Niroula R, Factor XIII, Deficiency. A review of clinical presentation and management. Hematol Oncol Clin North Am. 2021;35:1171\u201380.","journal-title":"Hematol Oncol Clin North Am"},{"key":"2169_CR8","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/hae.14223","volume":"27","author":"M Tarantino","year":"2021","unstructured":"Tarantino M. Occurrence and management of severe bleeding episodes in patients with hereditary factor X deficiency. Haemophilia. 2021;27:531\u201343.","journal-title":"Haemophilia"},{"key":"2169_CR9","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/hae.14986","volume":"30","author":"A Casini","year":"2024","unstructured":"Casini A, Al-Samkari H, Hayward C, Peyvandi F. Rare bleeding disorders: advances in management. Haemophilia. 2024;30:60\u20139.","journal-title":"Haemophilia"},{"key":"2169_CR10","doi-asserted-by":"publisher","first-page":"110","DOI":"10.17517\/ksutfd.540503","volume":"14","author":"C Acipayam","year":"2019","unstructured":"Acipayam C, Duyuran O, Akgungor F, Dincer Z. Newly diagnosis patients with a rare factor level: five years experience. KSU Med J. 2019;14:110\u20133.","journal-title":"KSU Med J"},{"key":"2169_CR11","doi-asserted-by":"publisher","first-page":"e24705","DOI":"10.1002\/jcla.24705","volume":"36","author":"J Yang","year":"2022","unstructured":"Yang J, Mao H, Sun L. Congenital coagulation factor V deficiency with intracranial hemorrhage. J Clin Lab Anal. 2022;36:e24705.","journal-title":"J Clin Lab Anal"},{"key":"2169_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13052-021-01152-y","volume":"47","author":"G Serra","year":"2021","unstructured":"Serra G, Antona V, Giuffr\u00e9 M, Pomi FL, Scalzo LL, Piro E. Novel missense mutation of the TP63 gene in a newborn with Hay-Wells\/Ankyloblepharon-Ectodermal Defects-Cleft Lip\/Palate (AEC) syndrome: clinical report and follow-up. Ital J Pediatr. 2021;47:196.","journal-title":"Ital J Pediatr"},{"key":"2169_CR13","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1055\/s-0036-1571339","volume":"42","author":"A Casini","year":"2016","unstructured":"Casini A, Moerloose P, Neerman-Arbez M. Clinical features and management of congenital fibrinogen deficiencies. Semin Thromb Hemost. 2016;42:366\u201374.","journal-title":"Semin Thromb Hemost"},{"key":"2169_CR14","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1538-7836.2012.04653.x","volume":"10","author":"F Peyvandi","year":"2012","unstructured":"Peyvandi F, Palla R, Menegatti M, Siboni SM, Halimeh S, Faeser B, et al. Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the European network of rare bleeding disorders. J Thromb Haemost. 2012;10:615\u201321.","journal-title":"J Thromb Haemost"},{"key":"2169_CR15","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1111\/j.1365-2516.2008.01910.x","volume":"15","author":"FH Herrmann","year":"2009","unstructured":"Herrmann FH, Wulff K, Auerswald G, Schulman S, Astermark J, Batorova A, et al. Greifswald factor FVII deficiency study Group. factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene. Haemophilia. 2009;15:267\u201380.","journal-title":"Haemophilia"},{"key":"2169_CR16","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2516.1997.00137.x","volume":"3","author":"F Peyvandi","year":"1997","unstructured":"Peyvandi F, Mannucci PM, Asti D, Abdoullahi M, Rocco N, Sharifian R. Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency. Haemophilia. 1997;3:242\u20136.","journal-title":"Haemophilia"},{"key":"2169_CR17","first-page":"396","volume":"8","author":"\u00d6 Terzi","year":"2023","unstructured":"Terzi \u00d6. Rare factor deficiencies in children: A review of 23 cases from a single center. Online Turkish J Health Sci. 2023;8:396\u2013401.","journal-title":"Online Turkish J Health Sci"},{"key":"2169_CR18","doi-asserted-by":"publisher","first-page":"934","DOI":"10.3324\/haematol.12211","volume":"93","author":"M Karimi","year":"2008","unstructured":"Karimi M, Menegatti M, Afrasiabi A, Sarikhani S, Peyvandi F. Phenotype and genotype report on homozygous and heterozygous patients with congenital factor X deficiency. Haematologica. 2008;93:934\u20138.","journal-title":"Haematologica"},{"issue":"5","key":"2169_CR20","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3324\/haematol.2011.049403","volume":"97","author":"A Branchini","year":"2012","unstructured":"Branchini A, Rizzotto L, Mariani G, Napolitano M, Lapecorella M, Giansily- Blaizot M, et al. Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency. Haematologica. 2012;97(5):705\u20139.","journal-title":"Haematologica"},{"key":"2169_CR21","doi-asserted-by":"crossref","unstructured":"Napolitano M, Siragusa S, Mariani G, Factor VII, Deficiency. Clinical Phenotype, genotype and therapy. J Clin Med. 2017,638.","DOI":"10.3390\/jcm6040038"},{"key":"2169_CR22","doi-asserted-by":"publisher","first-page":"232","DOI":"10.4274\/jarem.galenos.2020.3662","volume":"10","author":"N Eroglu","year":"2020","unstructured":"Eroglu N, Erduran E, Bahadir A, Saruhan H. Rare factor deficiencies: A retrospective, singlecenter cohort study. J Acad Res Med. 2020;10:232\u20136.","journal-title":"J Acad Res Med"},{"key":"2169_CR23","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MBC.0000000000000204","volume":"26","author":"D Tugcu","year":"2015","unstructured":"Tugcu D, Salcioglu Z, Akcay A, Sen HS, Aydogan G, Ak\u0131c\u0131 F, et al. How do we encounter rare factor deficiencies in children. Single-centre results from Turkey. Blood Coagul Fibrinolysis. 2015;26:145\u201351.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2169_CR24","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/00043426-200312001-00015","volume":"25","author":"M Bullinger","year":"2003","unstructured":"Bullinger M, Mackensen SV, Group H. Quality of life children and families with bleeding disorders. J Pediatr Hematol Oncol. 2003;25:64\u20137.","journal-title":"J Pediatr Hematol Oncol"},{"key":"2169_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1080\/00365513.2021.2013524","volume":"82","author":"A Akdeniz","year":"2022","unstructured":"Akdeniz A, \u00dcn\u00fcvar A, Ar MA, Pekpak E, Akyay A, Mehtap \u00d6, et al. Results of multicenter registry for patients with inherited factor VII deficiency in Turkey. Scand J Clin Lab Invest. 2022;82:28\u201336.","journal-title":"Scand J Clin Lab Invest"},{"key":"2169_CR26","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.3390\/genes14091767","volume":"14","author":"O Pshenichnikova","year":"2023","unstructured":"Pshenichnikova O, Selivanova D, Shchemeleva E, Abramova T, Zozulya N, Surin V. Molecular genetic analysis of Russian patients with coagulation factor FVII deficiency. Genes (Basel). 2023;14:1767.","journal-title":"Genes (Basel)"},{"key":"2169_CR27","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1055\/s-0044-1792031","volume":"51","author":"S Perrone","year":"2025","unstructured":"Perrone S, Raso S, Napolitano M. Clinical, Laboratory, and molecular characteristics of inherited vitamin K- dependent coagulation factors deficiency. Semin Thromb Hemost. 2025;51:170\u20139.","journal-title":"Semin Thromb Hemost"},{"key":"2169_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1471-2431-14-219","volume":"14","author":"C Schreiner","year":"2014","unstructured":"Schreiner C, Suter S, Watzka M, Hertfelder HJ, Schreiner F, Oldenburg J, Bartmann P, Heep A. Genetic variants of the vitamin K dependent coagulation system and intraventricular hemorrhage in preterm infants. BMC Pediatr. 2014;14:219.","journal-title":"BMC Pediatr"},{"key":"2169_CR29","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1111\/j.1365-2516.2008.01814.x","volume":"14","author":"P Mishra","year":"2008","unstructured":"Mishra P, Naithani R, Dolai T, Bhargava R, Mahapatra M, Dixit A, et al. Intracranial haemorrhage in patients with congenital haemostatic defects. Haemophilia. 2008;14:952\u20135.","journal-title":"Haemophilia"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-02169-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-02169-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T15:11:33Z","timestamp":1781622693000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13052-025-02169-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2169"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-02169-3","relation":{},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]},"assertion":[{"value":"8 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Bakirkoy Dr. Sadi Konuk Training and Research Hospital, Health Sciences University. This study was conducted in accordance with the ethical standards as laid down of the 1964 Declaration of Helsinki. Written consent was obtained from the legal guardian parent of each participating child.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6"}}